IN173570B - - Google Patents

Info

Publication number
IN173570B
IN173570B IN1094DE1989A IN173570B IN 173570 B IN173570 B IN 173570B IN 1094DE1989 A IN1094DE1989 A IN 1094DE1989A IN 173570 B IN173570 B IN 173570B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Lowe John Amams
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IN1094DE1989 priority Critical patent/IN173570B/en
Publication of IN173570B publication Critical patent/IN173570B/en

Links

IN1094DE1989 1989-11-23 1989-11-23 IN173570B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1094DE1989 IN173570B (de) 1989-11-23 1989-11-23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1094DE1989 IN173570B (de) 1989-11-23 1989-11-23

Publications (1)

Publication Number Publication Date
IN173570B true IN173570B (de) 1994-06-04

Family

ID=11092234

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1094DE1989 IN173570B (de) 1989-11-23 1989-11-23

Country Status (1)

Country Link
IN (1) IN173570B (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953855B2 (en) 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US7981906B2 (en) 2007-08-02 2011-07-19 Targacept, Inc. (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl-benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
US8476296B2 (en) 2009-01-26 2013-07-02 Targacept, Inc. Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide
US9724340B2 (en) 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124619B2 (en) 1998-12-11 2012-02-28 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US8084462B2 (en) 1998-12-11 2011-12-27 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US8124620B2 (en) 1998-12-11 2012-02-28 Targacept, Inc. 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US7425561B2 (en) 1998-12-11 2008-09-16 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US7754189B2 (en) 1998-12-11 2010-07-13 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US7767193B2 (en) 1998-12-11 2010-08-03 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US8124618B2 (en) 1998-12-11 2012-02-28 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US6953855B2 (en) 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US8158649B2 (en) 2003-02-21 2012-04-17 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US8143272B2 (en) 2003-02-21 2012-03-27 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
AU2004215386B2 (en) * 2003-02-21 2009-06-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US8541447B2 (en) 2003-02-21 2013-09-24 Targacept, Inc. 3-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof
EA011033B1 (ru) * 2003-02-21 2008-12-30 Таргасепт, Инк. 3-замещенные-2(арилалкил)-1-азабициклоалканы и способы их применения
US8846715B2 (en) 2007-08-02 2014-09-30 Targacept, Inc. (2S,3R)-N-(2((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide novel salt forms, and methods of use thereof
US7981906B2 (en) 2007-08-02 2011-07-19 Targacept, Inc. (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl-benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
US8541446B2 (en) 2007-08-02 2013-09-24 Targacept, Inc. (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurn-2-carboxamide, novel salt forms, and methods of use thereof
US8119659B2 (en) 2007-08-02 2012-02-21 Targacept, Inc. (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
US8476296B2 (en) 2009-01-26 2013-07-02 Targacept, Inc. Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide
US8901151B2 (en) 2009-01-26 2014-12-02 Targacept, Inc. Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide
US9724340B2 (en) 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods

Similar Documents

Publication Publication Date Title
DE4091597T (de)
DE4091978T (de)
IN171747B (de)
FR2646791B1 (de)
GR3005006T3 (de)
DK0415647T3 (de)
GR3006945T3 (de)
FR2648826B1 (de)
FR2649163B1 (de)
FR2654501B1 (de)
FR2646529B1 (de)
FR2653222B1 (de)
FR2651649B1 (de)
FR2650577B1 (de)
FR2646028B1 (de)
FR2656240B1 (de)
GR890200439U (de)
IN173807B (de)
GR2000488Y (de)
GR890200068U (de)
GR890200358U (de)
GR890200438U (de)
IN173766B (de)
HU896183D0 (de)
IN174358B (de)